Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 122

Results For "Men"

10107 News Found

India ramps up medical education with substantial investments
Policy | October 25, 2021

India ramps up medical education with substantial investments

A total of Rs 17,691.08 cr. invested in 157 new approved medical colleges since 2014


We plan to expand into Chennai, Hyderabad and Vijayawada: Rajinish Menon, Founder & CEO, Sukino Healthcare
interviews | October 20, 2021

We plan to expand into Chennai, Hyderabad and Vijayawada: Rajinish Menon, Founder & CEO, Sukino Healthcare

Continuum care is a concept that’s gaining acceptance in South India and Sukino Healthcare with its presence in Bangalore and Kochi has made rapid strides catering to this need. It now plans to expand to many more cities in the region. Indian Pharma Post caught up with Rajinish Menon, Founder & CEO, Sukino Healthcare who gave us an insight into the company’s operations.


NIH grants in-principle accreditation to Advanced Enzymes supplements
Healthcare | October 20, 2021

NIH grants in-principle accreditation to Advanced Enzymes supplements

The panel concurred that these supplements resolved post-Covid-19 fatigue and muscle weakness


MSN Labs launches drug for diabetes management
Drug Approval | October 19, 2021

MSN Labs launches drug for diabetes management

The company claims that its Empagliflozin tablets are the most affordable in India


Vertex’s stem cell therapy for Type 1 diabetes reduced daily insulin requirement by 91 %
Biotech | October 19, 2021

Vertex’s stem cell therapy for Type 1 diabetes reduced daily insulin requirement by 91 %

The first patient dosed with VX-880 demonstrated restoration of insulin production and achieved C-peptide of 560 pmol/L in response to Mixed Meal Tolerance Test (MMTT) at Day 90 visit


U.S. FDA approves Roche’s Tecentriq as adjuvant treatment for small cell lung cancer
Drug Approval | October 18, 2021

U.S. FDA approves Roche’s Tecentriq as adjuvant treatment for small cell lung cancer

Tecentriq is the first and only cancer immunotherapy approved for NSCLC in the adjuvant setting


U.S. FDA advisory committee recommends J&J booster dose
Biotech | October 18, 2021

U.S. FDA advisory committee recommends J&J booster dose

U.S. FDA to decide whether to authorize a booster dose in the coming days


Shilpa Medicare raises over Rs. 297 crore through preferential allotment
News | October 15, 2021

Shilpa Medicare raises over Rs. 297 crore through preferential allotment

Equity raise to finance growth and investments in the biological space


Hospitals to accelerate digital investments: Frost & Sullivan
Digitisation | October 14, 2021

Hospitals to accelerate digital investments: Frost & Sullivan

The survey revealed that improving customer experience (CX) and operational efficiencies are top priorities, which healthcare organizations aim to attain by deploying digital health solutions


Lonza to expand development services for mammalian products in Singapore
Biotech | October 13, 2021

Lonza to expand development services for mammalian products in Singapore

This expansion will support the global operations network and help meet global demand for mammalian development services that support Lonza’s manufacturing sites